[go: up one dir, main page]

FI841281L - NY FAKTOR FOER VIII COAGULENTA POLYPEPTIDER OCH DERAS MONOCLONALA ANTIKROPPAR. - Google Patents

NY FAKTOR FOER VIII COAGULENTA POLYPEPTIDER OCH DERAS MONOCLONALA ANTIKROPPAR. Download PDF

Info

Publication number
FI841281L
FI841281L FI841281A FI841281A FI841281L FI 841281 L FI841281 L FI 841281L FI 841281 A FI841281 A FI 841281A FI 841281 A FI841281 A FI 841281A FI 841281 L FI841281 L FI 841281L
Authority
FI
Finland
Prior art keywords
monoclonala
coagulenta
polypeptider
antikroppar
faktor
Prior art date
Application number
FI841281A
Other languages
Finnish (fi)
Other versions
FI841281A7 (en
FI841281A0 (en
Inventor
Theodore S Zimmermann
Carol A Fulcher
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27046849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI841281(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of FI841281A0 publication Critical patent/FI841281A0/en
Publication of FI841281A7 publication Critical patent/FI841281A7/en
Publication of FI841281L publication Critical patent/FI841281L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
FI841281A 1983-03-31 1984-03-30 NY FAKTOR FOER VIII COAGULENTA POLYPEPTIDER OCH DERAS MONOCLONALA ANTIKROPPAR. FI841281L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48110583A 1983-03-31 1983-03-31
US55650883A 1983-11-30 1983-11-30

Publications (3)

Publication Number Publication Date
FI841281A0 FI841281A0 (en) 1984-03-30
FI841281A7 FI841281A7 (en) 1984-10-01
FI841281L true FI841281L (en) 1984-10-01

Family

ID=27046849

Family Applications (1)

Application Number Title Priority Date Filing Date
FI841281A FI841281L (en) 1983-03-31 1984-03-30 NY FAKTOR FOER VIII COAGULENTA POLYPEPTIDER OCH DERAS MONOCLONALA ANTIKROPPAR.

Country Status (12)

Country Link
EP (3) EP0123945B2 (en)
JP (2) JPH0829089B2 (en)
AT (2) ATE135400T1 (en)
AU (1) AU572128B2 (en)
CA (1) CA1341506C (en)
DE (2) DE3486423T3 (en)
DK (2) DK172036B1 (en)
FI (1) FI841281L (en)
IE (2) IE80858B1 (en)
NO (1) NO167533C (en)
SG (2) SG49675A1 (en)
ZA (1) ZA842418B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657894A (en) * 1983-03-31 1987-04-14 Scripps Clinic & Research Foundation New factor VIII coagulant polypeptides
US4716117A (en) * 1984-10-26 1987-12-29 Chiron Corporation Monoclonal antibodies to factor VIIIC
US5004804A (en) * 1984-01-12 1991-04-02 Nordisk Gentofte Method and composition for preparation of factor VIIIC
US5045455A (en) * 1984-01-12 1991-09-03 Chiron Corporation Factor VIII:C cDNA cloning and expression
DK13485A (en) * 1984-01-12 1985-07-13 Chiron Corp HYBRIDOMA CELL LINE AND MONOCLONAL ANTIBODY OBTAINED BY A SUCH CELL LINE
US7138505B1 (en) 1984-01-12 2006-11-21 Novartis Vaccines And Diagnostics, Inc. Factor VIII:C nucleic acid molecules
ATE224445T1 (en) * 1984-01-12 2002-10-15 Chiron Corp DNA SEQUENCES CODING FOR FACTOR VIIIC AND RELATED DNA CONSTRUCTIONS
IL74909A (en) * 1984-04-20 1992-01-15 Genentech Inc Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
SE8501050D0 (en) * 1985-03-05 1985-03-05 Kabivitrum Ab BIOLOGICALLY ACTIVE FRAGMENTS OF HUMAN ANTIHEMOPHILIC FACTOR AND METHOD FOR PREPARATION THEREOF
KR910006424B1 (en) * 1985-08-21 1991-08-24 인코텍스 비.브이 Manufacturing method of knitted briefs
DE3788944T2 (en) * 1986-06-24 1994-05-26 Novonordisk As METHOD FOR PRODUCING A COAGULATION-ACTIVE COMPLEX FROM FACTOR VIII FRAGMENT.
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
EP0294910B1 (en) 1987-06-12 1996-09-11 Immuno Ag Novel proteins with factor VIII activity, process for their preparation using genetically engineered cells and pharmaceutical compositions containing them
IL88309A0 (en) * 1987-11-17 1989-06-30 Scripps Clinic Res Peptides for use in the purification of factor viii
FR2662166A1 (en) * 1990-05-18 1991-11-22 Fondation Nale Transfusion San PROCESS FOR PREPARING HIGHLY HIGH PURITY FACTOR VIII COMPRISING A RAPID IMMUNOADSORPTION STEP
AU7254894A (en) * 1993-07-23 1995-02-20 Baxter International Inc. Activated human factor viii and method of preparation
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
DK2130554T3 (en) 1999-02-22 2012-12-03 Univ Connecticut Albumin-free factor VIII preparations
WO2003013244A1 (en) 2001-08-03 2003-02-20 The Government Of The United State Of America, As Represented By The Secretary Of The Department Of Health And Human Services Oral treatment of hemophilia
ES2706296T3 (en) 2008-11-07 2019-03-28 Univ Connecticut Formulations of Factor VIII
BRPI1105317A2 (en) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto stable and large-scale production of human fviii in human cell line sk-hep-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364936A (en) * 1980-01-08 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human monocyte antigen and methods of preparing same
US4364937A (en) * 1980-01-08 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human T cell antigen and methods of preparing same
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4397841A (en) * 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C

Also Published As

Publication number Publication date
FI841281A7 (en) 1984-10-01
IE960783L (en) 1984-09-30
DE3486453D1 (en) 1997-08-21
EP0561427B1 (en) 1997-07-16
JPH0638790A (en) 1994-02-15
IE80638B1 (en) 1998-10-21
SG48229A1 (en) 1998-04-17
DK174984A (en) 1984-10-01
NO167533B (en) 1991-08-05
NO841277L (en) 1984-10-01
EP0123945B2 (en) 2000-04-19
ATE155490T1 (en) 1997-08-15
SG49675A1 (en) 1998-06-15
IE80858B1 (en) 1999-04-21
DK174984D0 (en) 1984-03-30
DE3486423T3 (en) 2001-02-08
NO167533C (en) 1991-11-13
EP0770396A2 (en) 1997-05-02
AU2627284A (en) 1984-10-04
ZA842418B (en) 1984-11-28
IE840788L (en) 1984-09-30
EP0123945A1 (en) 1984-11-07
JPH0829089B2 (en) 1996-03-27
JPS59184130A (en) 1984-10-19
EP0123945B1 (en) 1996-03-13
EP0770396A3 (en) 1997-07-23
DK172036B1 (en) 1997-09-22
DE3486423T2 (en) 1996-09-19
CA1341506C (en) 2006-06-06
EP0561427A1 (en) 1993-09-22
FI841281A0 (en) 1984-03-30
ATE135400T1 (en) 1996-03-15
DE3486453T2 (en) 1998-02-26
AU572128B2 (en) 1988-05-05
DE3486423D1 (en) 1996-04-18
DK50497A (en) 1997-05-02

Similar Documents

Publication Publication Date Title
FI852547A0 (en) FRAMSTAELLNING AV FAKTOR VIII OCH DAERTILL HOERANDE PRODUKTER.
FI841357L (en) POLYMERIDISPERSIONER OCH DERAS FRAMSTAELLNING.
FI841463L (en) MIKROPARTIKLAR OCH GASBLAOSOR INNEHAOLLANDE ULTRALJUDKONTRASTMEDEL.
FI841462L (en) MIKROPARTIKLAR OCH GASBLAOSOR INNEHAOLLANDE ULTRALJUDKONTRASTMEDEL.
FI841264L (en) POLERINGSKOMPOSITIONER OCH DAERI ANVAENDA POLERINGSAEMNEN.
FI841537A0 (en) ROTERANDE HANDKNIV OCH DELAR FOER DENSAMMA.
FI841054A7 (en) KOLMOLEKYLSILAR OCH FOERFARANDE FOER DERAS FRAMSTAELLNING OCH ANVAENDNING.
FI841055A7 (en) KOLMOLEKYLSILAR OCH FOERFARANDE FOER DERAS FRAMSTAELLNING OCH ANVAENDNING.
FI841281L (en) NY FAKTOR FOER VIII COAGULENTA POLYPEPTIDER OCH DERAS MONOCLONALA ANTIKROPPAR.
FI842336A0 (en) TERMISTORER OCH DERAS TILLVERKNING.
FI841555L (en) SJAELVUTJAEMNANDE POLERMEDELSKOMPOSITIONER OCH DAERI ANVAENDBARA POLYMERKOMPOSITIONER.
FI841417L (en) KULOERISERADE HYDROGELPLASTARTIKLAR OCH FOERFARANDE FOER KULOERISERING DAERAV.
FI844280L (en) OLJERESISTENT OCH FOERBRAENNING RETARDEKANDE AEMNESSAMMANSAETTNING.
FI840922A7 (en) STROEMFOLIEINDUKTORNAET OCH PULSFORMINGSSYSTEM.
FI843494L (en) BIOPOLYMERFORMATIONER OCH DERAS FRAMSTAELLNINGSFOERFARANDEN.
FI843933L (en) KEFALOSPORINDERIVAT OCH FOERFARANDE FOER DERAS FRAMSTAELLNING.
FI833333L (en) VAERMEISOLERAT LEDNINGSROER OCH FOERFARANDE FOER FRAMSTAELLNING DAERAV.
FI841590A7 (en) KONDENSERADE SJULEMMANDE RINGFOERENINGAR OCH DERAS ANVAEDNING.
FI840056L (en) STOEDSYSTEM FOER SAENGAR OCH LIKNANDE.
FI844494A0 (en) FOERBAETTRAD ATOMISERINGSANORDNING OCH SAETT FOER BRAENNARE FOER FLYTANDE BRAENSLE OCH ATOMISERINGSDON FOER VAETSKOR.
FI840004L (en) DITIOPHOSFOR/AMIN-SALTER OCH DESSA INNEHAOLLANDE VATTENHALTIGA KOMPOSITIONER.
FI833143L (en) KOL-VATTENBRAENSLEUPPSLAMNINGAR OCH FOERFARANDE FOER DERAS FRAMSTAELLNING.
FI840084A7 (en) VAETSKEFORMIGA VIDHAEFTANDE DESINFIERANDE AEMNESKOMPOSITIONER FOER UTVAERTES ANVAENDNING OCH FOERFARANDE FOER FRAMSTAELLNING DAERAV.
FI843630L (en) INRAETTNING FOER VEDKLYVNING OCH VEDHUGGNING.
FI843600L (en) PLASMIDVEKTORER OCH FOERFARANDE FOER FRAMSTAELLNING DAERAV.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SCRIPPS CLINIC AND RESEARCH FOUNDATION